Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intricacies and inter-relationships between HIV disclosure and HAART: a qualitative study.

R L Klitzman1, S B Kirshenbaum, B Dodge

  • 1HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, NY 10032, USA. rlk2@columbia.edu

AIDS Care
|June 30, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Embedding Physical Activity into Community-Based Peer Support Groups for those Severely Affected by Mental Illness.

International journal of environmental research and public health·2023
Same author

Gay fathers' motivations for and feelings about surrogacy as a path to parenthood.

Human reproduction (Oxford, England)·2017
Same author

A study of human papillomavirus on vaginally inserted sex toys, before and after cleaning, among women who have sex with women and men.

Sexually transmitted infections·2014
Same author

Idiopathic precocious puberty in girls: Psychosexual development.

Journal of youth and adolescence·2013
Same author

Fetal feminization and female gender identity in the testicular feminizing syndrome of androgen insensitivity.

Archives of sexual behavior·2013
Same author

Fetal hormones and the brain: Effect on sexual dimorphism of behavior-A review.

Archives of sexual behavior·2013

Highly active antiretroviral treatment (HAART) significantly impacts HIV disclosure. Managing medications can affect adherence and behaviors, while disclosure influences treatment support and adherence.

Area of Science:

  • Medical Sociology
  • Public Health
  • Infectious Diseases

Background:

  • HIV disclosure is a complex issue impacting treatment adherence.
  • The advent of Highly Active Antiretroviral Treatment (HAART) introduced new dynamics to HIV management.
  • Understanding the interplay between HAART, disclosure, and treatment decisions is crucial for patient care.

Purpose of the Study:

  • To investigate how HAART influences HIV disclosure patterns and perceptions.
  • To examine the reciprocal relationship between HIV disclosure and treatment adherence.
  • To identify how these interactions affect treatment decisions.

Main Methods:

  • Semi-structured interviews were conducted with 152 HIV-positive adults in the US.
  • Participants included men who have sex with men (MSM), women, and injection drug users (IDU) men.

Related Experiment Videos

  • Interviews explored experiences with HAART, disclosure, and treatment adherence.

    • Main Results:

    • HAART can inadvertently 'out' individuals due to medication visibility or side effects, impacting adherence and behavior.
    • Negative societal attitudes towards HAART can create barriers to disclosure and adherence.
    • Conversely, HAART can improve appearance, influencing disclosure timing or leading to denial of HIV status.
    • Disclosure can lead to social support, facilitating HAART initiation and adherence.
    • HIV disclosure and treatment adherence are shown to be mutually influential.

    Conclusions:

    • HAART significantly complicates HIV disclosure, affecting adherence and patient behaviors.
    • The relationship between HIV disclosure and HAART adherence is bidirectional and requires integrated study.
    • Current interventions often address disclosure and adherence separately; integrated approaches are needed to recognize their critical interactions.